Biller Scott - SEC Form 4 Insider Trading Screener
24 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
| S | 5 | +0 | -1 | -13 | +0 |
X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2018-09-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $83.07 | -3,000 | 57,196 | -5% | -$249,215 | |||||
| D | 2018-08-06 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $80.11 | -3,000 | 57,196 | -5% | -$240,333 | |||||
| D | 2018-07-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $83.50 | -3,000 | 57,196 | -5% | -$250,503 | |||||
| D | 2018-06-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $93.37 | -3,000 | 57,196 | -5% | -$280,101 | |||||
| D | 2018-05-23 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $90.00 | -15,177 | 57,196 | -21% | -$1,365,930 | |||||
| D | 2018-05-07 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $81.81 | -3,000 | 57,196 | -5% | -$245,430 | |||||
| D | 2018-04-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $75.20 | -3,000 | 57,196 | -5% | -$225,607 | |||||
| D | 2018-03-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $83.08 | -3,000 | 53,059 | -5% | -$249,229 | |||||
| D | 2018-02-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $76.04 | -3,000 | 53,059 | -5% | -$228,128 | |||||
| D | 2018-01-10 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $65.00 | -3,000 | 53,059 | -5% | -$195,000 | |||||
| D | 2017-12-01 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $60.79 | -2,146 | 6,264 | -26% | -$130,459 | |||||
| D | 2017-11-01 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $62.69 | -2,146 | 6,264 | -26% | -$134,522 | |||||
2017-10-04 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale | $70.00 | -10,470 | 6,264 | -63% | -$732,900 | ||||||
| D | 2017-10-02 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $67.23 | -2,146 | 16,734 | -11% | -$144,276 | |||||
2017-09-11 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale | $65.00 | -15,000 | 16,734 | -47% | -$975,000 | ||||||
| D | 2017-09-01 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $61.99 | -2,146 | 31,734 | -6% | -$133,031 | |||||
| DM | 2017-08-01 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $59.60 | -23,146 | 31,734 | -42% | -$1,379,397 | |||||
| D | 2017-07-07 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $55.00 | -2,146 | 52,734 | -4% | -$118,030 | |||||
| D | 2017-06-21 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $55.00 | -4,292 | 49,734 | -8% | -$236,060 | |||||
| D | 2017-04-03 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $58.03 | -2,146 | 46,734 | -4% | -$124,532 | 0 | 0 | -11 | ||
| D | 2017-03-20 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $55.00 | -6,438 | 46,470 | -12% | -$354,090 | +2 | +6 | -9 | ||
| D | 2016-11-14 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale+OE | $65.00 | -32,500 | 54,270 | -37% | -$2,112,500 | +1 | 0 | -9 | ||
| M | 2016-11-09 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale | $60.00 | -5,000 | 59,270 | -8% | -$300,000 | 0 | -7 | -23 | ||
2016-10-05 | AGIO | Biller Scott | Chief Scientific Officer | S - Sale | $55.00 | -5,000 | 64,270 | -7% | -$275,000 | -2 | -6 | -11 | 0 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |